Oruka Therapeutics Stock Alpha and Beta Analysis
| ORKA Stock | 27.65 1.25 4.73% |
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as Oruka Therapeutics. It also helps investors analyze the systematic and unsystematic risks associated with investing in Oruka Therapeutics over a specified time horizon. Remember, high Oruka Therapeutics' alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to Oruka Therapeutics' market risk premium analysis include:
Beta 1.05 | Alpha 0.4 | Risk 3.87 | Sharpe Ratio 0.0331 | Expected Return 0.13 |
Enterprise Value |
|
Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
Check out Oruka Therapeutics Backtesting, Oruka Therapeutics Valuation, Oruka Therapeutics Correlation, Oruka Therapeutics Hype Analysis, Oruka Therapeutics Volatility, Oruka Therapeutics History and analyze Oruka Therapeutics Performance. Oruka Therapeutics Market Premiums
Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. Oruka Therapeutics market risk premium is the additional return an investor will receive from holding Oruka Therapeutics long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Oruka Therapeutics. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate Oruka Therapeutics' performance over market.| α | 0.40 | β | 1.05 |
Oruka Therapeutics expected buy-and-hold returns
Although buy-and-hold investment strategy may not appeal to all investors, it may be used as a good measure of Oruka Therapeutics' Buy-and-hold return. Our buy-and-hold chart shows how Oruka Therapeutics performed over your current time horizon against a typical interest-earning bank account and a selected benchmark.Oruka Therapeutics Market Price Analysis
Market price analysis indicators help investors to evaluate how Oruka Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Oruka Therapeutics shares will generate the highest return on investment. By understating and applying Oruka Therapeutics stock market price indicators, traders can identify Oruka Therapeutics position entry and exit signals to maximize returns.
Oruka Therapeutics Return and Market Media
The median price of Oruka Therapeutics for the period between Sat, Oct 11, 2025 and Fri, Jan 9, 2026 is 28.11 with a coefficient of variation of 8.4. The daily time series for the period is distributed with a sample standard deviation of 2.37, arithmetic mean of 28.21, and mean deviation of 1.7. The Stock received substential amount of media coverage during this period. Price Growth (%) |
| Timeline |
1 | Is Oruka Therapeutics Inc. stock a momentum leader - 2025 Market WrapUp Long-Term Capital Growth Strategies - newser.com | 11/05/2025 |
2 | Why Oruka Therapeutics Inc. stock is trending on social media - Quarterly Market Summary Free High Return Stock Watch Alerts - newser.com | 11/19/2025 |
3 | Oruka Therapeutics stock hits 52-week high at 30.29 USD - Investing.com | 11/24/2025 |
4 | Oruka Therapeutics stock hits 52-week high, reaching 31.01 By Investing.com - Investing.com Nigeria | 12/05/2025 |
5 | Disposition of 3080 shares by Goncalves Joana of Oruka Therapeutics at 31.579 subject to Rule 16b-3 | 12/19/2025 |
6 | Oruka Therapeutics Trading Down 3.3 percent - Time to Sell - MarketBeat | 12/30/2025 |
7 | Disposition of 5000 shares by Laura Sandler of Oruka Therapeutics at 7.8 subject to Rule 16b-3 | 01/02/2026 |
8 | Oruka Therapeutics, Inc. Receives Consensus Recommendation of Moderate Buy from Brokerages - MarketBeat | 01/05/2026 |
About Oruka Therapeutics Beta and Alpha
For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including Oruka or other stocks. Alpha measures the amount that position in Oruka Therapeutics has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
| 2010 | 2025 | 2026 (projected) | Dividend Yield | 1.0 | 0.9 | 0.8 | Price To Sales Ratio | 614.26 | 2.4 | 2.28 |
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Oruka Therapeutics in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Oruka Therapeutics' short interest history, or implied volatility extrapolated from Oruka Therapeutics options trading.
Build Portfolio with Oruka Therapeutics
Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.Build Diversified Portfolios
Align your risk with return expectations
Check out Oruka Therapeutics Backtesting, Oruka Therapeutics Valuation, Oruka Therapeutics Correlation, Oruka Therapeutics Hype Analysis, Oruka Therapeutics Volatility, Oruka Therapeutics History and analyze Oruka Therapeutics Performance. For information on how to trade Oruka Stock refer to our How to Trade Oruka Stock guide.You can also try the Content Syndication module to quickly integrate customizable finance content to your own investment portal.
Oruka Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.